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ABSTRACT
Modifications of ribosomal RNA expand the nu-
cleotide repertoire and thereby contribute to ribo-
some heterogeneity and translational regulation of
gene expression. One particular m5C modification of
25S ribosomal RNA, which is introduced by Rcm1p,
was previously shown to modulate stress responses
and lifespan in yeast and other small organisms.
Here, we report that NSUN5 is the functional or-
thologue of Rcm1p, introducing m5C3782 into hu-
man and m5C3438 into mouse 28S ribosomal RNA.
Haploinsufficiency of the NSUN5 gene in fibroblasts
from William Beuren syndrome patients causes par-
tial loss of this modification. The N-terminal domain
of NSUN5 is required for targeting to nucleoli, while
two evolutionary highly conserved cysteines mediate
catalysis. Phenotypic consequences of NSUN5 defi-
ciency in mammalian cells include decreased prolif-
eration and size, which can be attributed to a reduc-
tion in total protein synthesis by altered ribosomes.
Strikingly, Nsun5 knockout in mice causes decreased
body weight and lean mass without alterations in
food intake, as well as a trend towards reduced pro-
tein synthesis in several tissues. Together, our find-
ings emphasize the importance of single RNA mod-
ifications for ribosome function and normal cellular
and organismal physiology.
INTRODUCTION
Control of cell size and proliferation are integral, but clearly
separated processes with many underlying mechanisms re-
maining unexplained. Our current understanding is that
both intrinsic developmental programs and extracellular
signals control cell number and cell size (1), ultimately con-
tributing to growth of whole organisms (2). Extracellu-
lar signals, such as genome size, metabolism, or nutrient
availability and -uptake, impinge on important cellular sig-
nalling hubs such as the mTOR pathway (3) or the tran-
scription factor Myc (4) that simultaneously control vari-
ous anabolic processes. Protein synthesis is one of those and
requires tight regulation by mTOR and Myc as energy de-
mands are exceptionally high (5).
The conversion of mRNA blueprints to functional
polypeptide chains is carried out by ribosomes. These large
molecular machines are composed of proteins and RNA
and were formerly seen as a static and homogenous popu-
lation, performing protein synthesis in a constitutive man-
ner. In recent years, however, it became evident that mam-
malian ribosomes rather represent dynamic structures that
can respond to certain stimuli by adapting their structure
and function (6,7). This heterogeneity can be generated
by changes in stoichiometry and modification patterns of
any of the ∼80 core ribosomal proteins (RPs), or their
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association with other factors. Importantly, 2–3% of the
7000 nucleotides distributed over the four ribosomal RNAs
(rRNA) are decorated with post-transcriptional modifica-
tions (8), which are introduced either by specific small nu-
cleolar RNA (snoRNA)-driven or stand-alone snoRNA-
independent enzymes (8,9). RNAmodifications expand the
naturally limited properties of the four nucleotides and
thereby contribute to ribosome heterogeneity by adapting
rRNA stability, structure and function. Apart from more
abundant 2′-O-ribosemethyls and pseudouridines (), only
five types of base modifications, namely acetylated cytosine
(ac4C) and N,N-dimethyladenosine (m62A) on the small
subunit (SSU), as well as N1-methyladenosine (m1A), N3-
methyluridine (m3U) and C5-methylcytosine (m5C) on the
large subunit (LSU) are each present twice per ribosome
in yeast, indicating a particularly beneficial role in terms of
chemical stability and structure (10). Similarly, according to
current estimations human 18S rRNAcarries two ac4C, two
m62A, oneN-methylguanosine (m7G) and oneN-methyl-N-
aminocarboxypropylpseudouridine (m1acp3), while 28S
rRNA is decorated with one m1A, two m5C and two m3U.
Intriguingly, the positions of most modified residues are
highly conserved from yeast to humans and occur in, or in
close proximity to functionally important sites, such as the
decoding site (DCS), the peptidyl transferase centre (PTC)
or the subunit interface (8–11). Prokaryotes and eukary-
otes share the majority of modifications in the inner core
of the ribosome, while eukaryotes have evolved an addi-
tional shell of modifications around the centre of ribosomes
(11). This enlarged complexity suggests that eukaryotes de-
veloped mechanisms for fine-tuning protein synthesis at the
level of rRNA modifications. Changes of those, together
with stoichiometric alterations of the protein component
and post-translational modifications have led to the ‘spe-
cialized ribosome’ concept of translational control (6,7).
We recently reported that lack of a single, conserved C5-
methylation at 25S rRNA residue C2278 (yeast nomen-
clature) alters ribosomal structure and translational fi-
delity, resulting in a ‘reprogramming’ of the ribosome to-
wards translation of mRNAs involved in cellular stress-
responses. Importantly, lack of this methylation by dele-
tion of homologs of human NSUN5 extended the lifespan
and stress resistance of yeast, worms and flies (12). NSUN5
is a conserved RNA methyltransferase belonging to the
Nop2/SUNdomain family. So far the only known substrate
of the yeast homolog of NSUN5, Rcm1, is C2278 of 25S
rRNA (12–14), while C2381 of 26S rRNA is the substrate
of NSUN-5, the Caenorhabditis elegans homolog (12) and
C3782 of human NSUN5 (15). Furthermore, NSUN5 is
among 25 heterozygously deleted genes in the rare develop-
mental disorder Williams Beuren syndrome (WBS; OMIM
194050), which is caused by amicrodeletion at chromosome
region 7q11.23 (16–18). Since recent studies found cognitive
deficits in Nsun5 knockout mice (19–21) and WBS patients
show neural abnormalities (22), NSUN5 might contribute
to the pathology ofWBS. Apart fromWBS, NSUN5 is also
associated with cancer. Recently, down-regulation of this
gene by epigenetic silencing was shown to promote long-
term survival of glioma patients and to render gliomasmore
sensitive to bioactive compounds generating oxidative stress
(15).
As removal of a single modification of rRNA can already
alter the physiology of simple model organisms and impair
cognitive function in mice, it becomes evident that a better
understanding of these processes in humans is important.
This knowledge might then contribute to the development
of strategies for improving health of aged subjects,WBS and
glioma patients, as well as to further decipher the impact of
rRNA modifications on normal physiology.
In this study, we report that loss of NSUN5 decreases
growth, cell size and proliferation, as well as bulk protein
translation. Moreover, we characterize human NSUN5 re-
garding its methylation target site, catalytical function, and
cellular localization.
MATERIALS AND METHODS
Methods referring to Supplementary Figures S1–S8, as well
as detailed protocols for some of the experimental proce-
dures listed here are provided as supplementary material.
Cells, animals and ethics
HeLa and HEK293 cells were purchased from ATCC.
HeLa cells were cultured in RPMI (F1215, Biochrom) and
HEK293 cells in DMEM (F0435, Biochrom), each sup-
plemented with 10% fetal calf serum (FCS) and 4mM L-
glutamine (G7513; Sigma).
Human dermal fibroblasts (HDF) from healthy female
donors were obtained from Evercyte GmbH (Vienna, Aus-
tria). The two dermal fibroblast strains from Williams
Beuren Syndrome (WBS) patients were a kind gift from
Dr. Aleksander Hinek (The Hospital for Sick Children,
Toronto, Canada). WBSCR14073 was isolated from a skin
biopsy of a 6 years old male patient and WBSCR14966
from a skin biopsy of a 3 months old female patient as
described previously. Both strains show haploinsufficiency
of the NSUN5 gene (23). All human dermal fibroblast
strains were cultured in DMEM/Ham’s F-12 (1:1 mixture)
(F4815, Biochrom) supplemented with 10% FCS and 4mM
L-glutamine (G7513; Sigma). All cell lines and strains were
tested for the absence of mycoplasms regularly and kept at
37◦C, 7% CO2 and 90% humidity.
NSUN5 knockout mice were generated by Applied Stem
Cell Inc. by disruption of exon 1 and intron 1 with two
loxP-sites by CRISPR-Cas9. Mice were crossed into the
C57BL/6J background 10 times. Experiments with Nsun5
knockout mice were approved by the animal ethics com-
mission of the Medical University of Vienna and by the
Austrian Federal Ministry of Education, Science and Re-
search (BMBWF-66.009/0199-V/3b/2018). The genera-
tion of anti-NSUN5 antibodies was approved by the Aus-
trian Federal Ministry of Science and Research (BMWF-
66.016/6-II/3b/2011).
Isolation and immortalization of mouse embryonic fibroblasts
Embryos from homozygous mating were isolated between
E 12.5 and E 14.5. After removing the heads, embryos were
minced and incubated with trypsin-EDTA (0.25%) at 37◦C
for 30 min. Mouse embryonic fibroblast (MEF) cell lines
were generated according to (24) and cultured in DMEM
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(F0435, Biochrom), supplemented with 10% FCS, 4 mML-
glutamine and 0.1 mM -mercaptoethanol.
Antibodies
The following primary and secondary antibodies were used
for western blot (WB) and immunofluorescence (IF) at in-
dicated dilutions:
Target Manufacturer Product # Host Conjugate WB IF
NSUN5 Santa Cruz sc-376147 Mouse – 1:250 1:100
NSUN5 selfmade – Mouse – 1:2000 1:250
-Actin Sigma A-5441 Mouse – 1:5000 –
GAPDH Thermo Fisher
Scientific
MA5-15738 Mouse – 1:5000 –
Fibrillarin Abcam ab5821 Rabbit – – 1: 1000
KRAS,
HRAS
and
NRAS
Abcam ab55193 Mouse – 1:1000 –
GFP Abcam ab290 Rabbit – 1:2500
Mouse
IgG
Jackson
Immunoresearch
115-485-146 Goat Dyelight
488
– 1: 1000
Rabbit
IgG
Jackson
Immunoresearch
111-485-144 Goat Dyelight
488
– 1: 1000
Rabbit
IgG
Jackson
Immunoresearch
111-505-144 Goat Dyelight
549
– 1: 1000
Rabbit
IgG
Jackson
Immunoresearch
111-495-144 Goat Dyelight
649
– 1: 1000
Mouse
IgG
Life Technologies O6380 Goat Oregon
Green 488
– 1: 1000
Rabbit
IgG
Jackson
Immunoresearch
111-065-144 Goat Biotin – 1: 1000
Mouse
IgG
Life Technologies A21057 Goat Alexa
Fluor 680
1:10 000 –
Rabbit
IgG
Licor 926-32211 Goat IRDye
800CW
1:10 000 –
For the generation of the polyclonal mouse NSUN5 an-
tibody, recombinant HIS-tagged NSUN5 was expressed in
Escherichia coli in the pET30a vector and purified using
Ni-NTA Agarose beads (Qiagen) under denaturing condi-
tions following the manufacturer’s protocol. Recombinant
HIS-NSUN5was used for the immunization of mice. Crude
serum from a single mouse was used. A characterization of
this antibody is shown in Supplementary Figure S8.
Generation of NSUN5 KO HeLa cells by CRISPR–Cas9
After reaching 80% confluence, HeLa cells were transfected
with an all-in-one plasmid encoding the guide RNA (CTTC
ACGTTCTGTGTGGCCG, designed by gUIDEbook™),
as well as Cas9 and GFP (Horizon Discovery Ltd, Free
CRISPR Knockout Generation Program). One day after
transfection, 105 GFP-positive cells were isolated with a
MoFlo Astrios cell sorter (Beckman Coulter) into a 12-
well cell culture plate. On the next day, we performed single
cell dilution in 96-well cell culture plates. Clones originat-
ing from single cells were screened for NSUN5 expression
using western blot and immunofluorescence with the self-
made polyclonal NSUN5 mouse antibody.
Multiple protein sequence alignment of Rcm1p and NSUN
family members
Amultiple protein sequence alignment of Rcm1p (UniPro-
tKB: P53972), NSUN1 (UniProtKB: P46087), NSUN2
(UniProtKB: Q08J23), NSUN3 (UniProtKB: Q9H649),
NSUN4 (UniProtKB: Q96CB9), NSUN5 (UniProtKB:
B2RD09), NSUN6 (UniProtKB: Q8TEA1) and NSUN7
(UniProtKB: Q8NE18) was performed with T-Coffee Ver-
sion 11.00.8cbe486 (25). Clustal colouring was applied.
From this alignment a phylogenetic tree with average dis-
tances using BLOSSUM62 was constructed in JalView
2.10.5 (26).
Cell number and cell size determination
Viable cell number and cell size were determined by ViCell
XR (Beckmann Coulter). 0.5−1 × 105 cells per well were
seeded in 6-well culture plates and total viable cell numbers
were determined on consecutive days until 100% confluency
was reached. Microscopic images were acquired with an in-
verted microscope (Leica, DM IL LED) using a 10×/NA
0.22 objective and phase contrast. Insertion of scale bars,
as well as brightness and contrast adjustments were done
with ImageJ (Version 1.52 e).
Weight and body composition measurement
Mice of the same litter were weighed at either 4 or 8 weeks
of age. Weight ratio per litter was calculated according to
this formula, with 2–4 mice per litter:
weight ratio = mean weight Nsun5
−/− animals [g]
mean weight Nsun5+/+ animals [g]
Body composition of awake un-anesthetized male and fe-
male mice between 14 and 18 weeks of age was analysed
using EchoMRI-100H (EchoMRI LCC) in a non-invasive
manner. The weight of these mice was also recorded.
Food intake
Male mice between 15 and 19 weeks of age were caged sep-
arately. After an adaption period of one week, food was
weighed on four consecutive days and the mean food intake
of each mouse was calculated.
Generation and stable transfection of GFP-mNsun5 BACmid
GFP-mNsun5 BACmid was generated by fusing mouse
Nsun5 contained in a BAC-clone to the C-terminus of
EGFP using the NFLAP tagging cassette (27) by the Quick
& Easy BAC Modification Kit (GeneBridges). The GFP-
mNsun5 BACmid was amplified in E. coli and purified
using the Large Construct Purification Kit (Qiagen) fol-
lowing the manufacturer´s instructions. Transfection into
HeLa cells was performed using Metafectene Pro (Biontex
GmbH) following the manufacturer’s instructions. Three
days after transfection, 800 g/ml G418 were applied for
selection. Single colonies emerged two weeks after transfec-
tion and were screened for GFP-mNsun5 expression and
correct intracellular localization by western blot and fluo-
rescence microscopy.
Site directed mutagenesis of NSUN5 in pCI-neo and lentivi-
ral vectors
The QuickChange II Site-Directed Mutagenesis Kit (Agi-
lent) was applied for exchanging C308 and C359 of NSUN5
D
ow
nloaded from
 https://academ
ic.oup.com
/nar/advance-article-abstract/doi/10.1093/nar/gkz1043/5624972 by U
niversitaetsbibliothek Bern user on 13 N
ovem
ber 2019
4 Nucleic Acids Research, 2019
in pCI-neo to serines following the manufacturer’s in-
structions. For producing lentiviral particles, the cDNA
sequence of wildtype NSUN5 and the two point mu-
tants, C308S and C359S, were cloned into the pLVX-
IRES-Hyg expression plasmid (Takara) using In-Fusion®
HD Cloning (Takara) with a sense (5′- CGGTGAATTC
CTCGAATGGGGCTGTATGCTGCAG-3′) and an anti-
sense (5′-TAGAACTAGTCTCGACTATGTGCAAGGC
GGTGTGC-3′) primer at the XhoI restriction site.
Generation of NSUN5-GFP truncation mutants
The following full-length and truncated versions ofNSUN5
were generated by PCR from HeLa cDNA (numbers repre-
sent amino acids counted from the N-terminus of the pro-
tein, bold letters indicate restriction sites): NSUN5(1–466)-
GFP (5′-gataCTCGAGatggggctgtatgctgcagctgc-3′ and 5′-t
tagGAATTCatgtgcaaggcggtgtgcaag-3′), NSUN5(1–121)-
GFP (5′-gataCTCGAGatggggctgtatgctgcagctgc-3′ and 5′
-ttagGAATTCccaggtcctcattccggctcacac-3′), NSUN5(1-
277)-GFP (5′-gataCTCGAGatggggctgtatgctgcagctgc-3′ an
d 5′-ttagGAATTCaagagacgccagcccgggcca-3′), NSUN5(1–
428)-GFP (5′-gataCTCGAGatggggctgtatgctgcagctgc
-3′ and 5′-ttagGAATTCatggcacctcgacccgttcaatta-3′),
NSUN5(121–466)-GFP (5′-gataCTCGAGatgttgg
aagtgggatccaggcctg-3′ and 5′-ttagGAATTCatg
tgcaaggcggtgtgcaag-3′), NSUN5(277–466)-GFP
(5′-gataCTCGAGatgtgctgtgaactggctgaggagg-3′ and 5′
-ttagGAATTCatgtgcaaggcggtgtgcaag-3′). Purified PCR
products were cloned into pEGFP-N1 by restriction digest
with XhoI and EcoRI.
Transfection of mammalian cells
Cells were grown to ∼80% confluence in six-well cell cul-
ture plates and transfected according the manufacturer’s
instructions (jetPRIME Polyplus). Lentiviruses contain-
ing NSUN5, C308S and C359S were produced by co-
transfecting Lenti-XHEK-293T cells with the recombinant
pLVX-IRES-Hyg plasmid and a Lenti-X Packaging Single
Shot (Takara) following the supplier’s instructions. One day
after infection of NSUN5 KO HeLa and MEF −/− cells
with virus particles, antibiotic selection (400 g/ml hy-
gromycin) was initiated. After 5 days of selection, stably
expressing cells were expanded and passaged at least three
times in media containing 200 g/ml hygromycin before
starting experiments.
RNA isolation and cDNA synthesis
Cells were lysed in TRI Reagent (Sigma) and RNA was
isolated following the manufacturer’s protocol. Total RNA
was isolated with Direct-zol™ RNA Kit (Zymo Research).
RNA quality and concentration were quantified with an
ND-1000 (NanoDrop) spectrometer. cDNA was synthe-
sized from500 ng of totalRNAusingHigh-Capacity cDNA
Reverse Transcription Kit (Life Technologies).
RT-qPCR
Target gene expression levels were quantified from cDNA
using the 5× HOT FIREPol® EvaGreen® qPCR Mix
Plus (Medibena) on a Rotor-Gene Q cycler (Qiagen)
with gene-specific primers: GAPDH (human): 5′-CGACC
ACTTTGTCAAGCTCA-3′ and 5′-TGTGAGGAGGG
GAGATTCAG-3′, Actb (mouse): 5′-AGAGGGAAATC
GTGCGTGAC-3′ and 5′-CAATAGTGATGACCTGG
CCGT-3′, NSUN5 (human): 5′-CTACCATGAGGTCCA
CTACAT-3′ and 5′-CTGGCAGAGGGAGCA-3′, Nsun5
(mouse): 5′-TTGCAAGAGAGCTCCAGACC-3′ and 5′-A
GGCAGCAAGGGATCCAAAA-3′.
Western blots
Cells and mouse kidneys were lysed in RIPA-buffer (150
mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, 0.1%
SDS, 50 mM Tris/HCl pH 8.0), sonicated for 30 cy-
cles (30 s on/30 s off) with a Bioruptor Plus sonica-
tor (Diagenode), centrifuged briefly and mixed with SDS-
PAGE sample buffer (60 M Tris/HCl pH 6.8, 2% SDS,
10% glycerol, 0.0125% bromophenol blue and 1.25% -
mercaptoethanol). Electrophoresis was performed using 4–
15% Mini-PROTEAN® TGX Gels (BioRad) in Laemmli-
Buffer (25 mM Tris, 250 mM glycine and 0.1% SDS) (28).
Protein bands were transferred to PVDF-membranes (Bio
Rad) at 25 V and 1.3 A for 3 min. After blocking and anti-
body incubations, detection was performed on the Odyssey
Infrared Imager (LI-COR).
Immunofluorescence staining of cells for gSTED
Cells were seeded onto coverslips, fixed in 4% formalde-
hyde and permeabilized in 1% Triton X-100. After incu-
bation with primary antibodies, cells were stained with
Oregon Green 488 anti-mouse and biotin anti-rabbit an-
tibodies. Thereafter, coverslips were incubated with V500-
streptavidin (BectonDickinson) andmounted withMowiol
(Sigma). Imaging was performed on a SP8 confocal micro-
scope equipped with a pulsed white-light laser and gSTED
(Leica Microsystems). Deconvolution of images was per-
formedwithHuygens Professional (ScientificVolume Imag-
ing). Cropping, insertion of scale bars and brightness and
contrast adjustments were done with Image J (Version 1.52
e).
Actinomycin D and -amanitin exposure
Actinomycin D and -amanitin treatment was performed
as previously described (29). HeLa cells were seeded into
-slides (ibidi GmbH) and incubated over night at 37◦C.
On the next day, cells were incubated with 50 ng/ml Acti-
nomycin D (Sigma) or with 50 g/ml -amanitin (Sigma)
for 2 h. Immunofluorescence staining forNSUN5 (selfmade
polyclonal mouse NSUN5 antibody) was performed as de-
scribed above.
Bisulfite conversion, PCR amplification and sequencing
Bisulfite conversion of 750 ng DNAse I (Zymo Re-
search) digested total RNA was performed using the
EZ RNA Methylation™ Kit (Zymo Research). The con-
verted RNA was eluted in 15 l nuclease-free water and
reverse-transcribed as described above. cDNA after bisul-
fite conversion was amplified by PCR using GoTaq®
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DNA polymerase (Promega), forward primer (5′-GG
GAGTAATTATGATTTTGACAAGGTAG-3′) and re-
verse primer (5′-ATAATAAATAAAAACAATAAAAAT
CTCATTCATCCATTCATACAC-3′) to generate a 101
bp PCR product. After purification by agarose gel elec-
trophoresis and QIAquick PCR Purification Kit (Qiagen),
DNAwas either used for COBRA assay (see below) or sub-
jected to TOPO cloning using the TOPO TA Cloning Kit
for Sequencing (Life Technologies) following the manufac-
turer’s protocol. Purified plasmids of the indicated number
of clones were analysed by Sanger sequencing (EurofinsGe-
nomics).
Combined bisulfite restriction analysis (COBRA)
COBRA was performed as previously described (13) with
minor modifications: The PCR product after bisulfite con-
version and reverse transcription was digested with MseI
(New England Biolabs), resulting in either two products of
45 and 56 bp (methylated) or three bands at 16, 29 and 56 bp
(non-methylated). Digested DNA samples were separated
on a 20% TBE gel (Life Technologies) followed by incuba-
tion for 20 min with SYBR Safe (Life Technologies). The
mean density of individual bands was quantified in Image J
(Version 1.52 e) and relative methylation [%] was calculated
according to this formula:
relative methylation [%]
= methylated (45 bp band)
methylated (45 bp band) + non methylated (29 bp band)×100
O-Propargyl-puromycin (OPP) assay
OPP assays were performed as described previously (30).
Two specificity controls were included: (i) cells not la-
belled with OPP and (ii) cells incubated with cycloheximide
(#C7698, Sigma) at a final concentration of 50 g/ml for
15 min prior to, as well as during incubation with OPP.
For quantitation of OPP labeling, cells were analysed by
flow cytometry. Selection of whole single cells in G1 phase
was based on forward and side scatter, as well as on DAPI
staining. Analysis of fluorescence intensities was performed
in Kaluza 1.2 (Beckman Coulter).
OPP labeling in vivo
Mice at the age of 4–6 months were weighed and OPP was
injected intraperitoneally at a concentration of 49.5 mg/kg
of body weight (10 mM OPP in PBS, 10 l/g). Vehicle
control mice were injected with the appropriate amount of
PBS. For these experiments, male mice were used, except
for four female vehicle control mice. One hour after in-
jection, mice were sacrificed by cervical dislocation. Bone
marrow cells were obtained by flushing the femur and tibia
with PBS/EtOH (70%). Single cell suspensions of liver, kid-
ney and lung were prepared by washing the tissues in PBS,
followed by cutting and incubation with collagenase NB4
(17454, Serva) in DMEM/Ham’s F12 (1.7 mg/ml) at 37◦C
for 30 min. The suspension was pushed through a G23 nee-
dle for several times into a petri dish and filtered through
a cell strainer (40 m). After centrifugation, cells were in-
cubated with DNase I in DMEM/Ham’s F12 (5 U/ml)
at room temperature for 10 min. Cells were harvested by
centrifugation, fixed in 1 ml cold EtOH (70%) and stored
at 4◦C. For visualization of OPP incorporation, cells were
treated as described above. For improved comparison of the
two independent experiments, OPP labelled samples were
normalized to the mean of the respective PBS controls.
Polysome profiling
Cells were grown to ∼80% confluence and treated with 100
g/ml cycloheximide for 10 min at 37◦C. Subsequently,
cells were washed twice with ice-cold PBS containing 100
g/ml cycloheximide and then resuspended in lysis buffer
(30 mM HEPES–KOH pH 7.6, 150 mM KOAc, 5 mM
MgOAc2, 4 mM DTT, RiboLock RNase Inhibitor (Ther-
moFisher Scientific), 1× cOmplete™ Protease Inhibitor
Cocktail (Roche), 100 g/ml cycloheximide). Cell mem-
branes were disrupted by passing through a 23G needle
for 25 times. Cell debris was removed by centrifugation at
∼15000 g for 15 min and the resulting cleared cell lysate
was layered on a linear 10–50% (w/v) sucrose gradient pre-
pared in buffer containing 30 mM HEPES–KOH pH 7.6,
150 mMKOAc, 5 mMMgOAc2, 4 mMDTT, 1 mMPMSF,
100 g/ml cycloheximide and centrifuged for 2 h 45 min
at 39 000 rpm in a Beckman SW41 rotor at 4◦C. The gra-
dient was then fractionated using a Brandel density gradi-
ent fractionation system. Polysome profiles were generated
by continuous measurement of the absorbance at 254 nm.
Polysome profiles within one biological replicate were nor-
malized to the same square area under the entire profile and
the peak area ratio between control HeLa and NSUN5 KO
was subsequently calculated.
In vitro translation assay
Cells were grown to ∼80% confluence, washed twice with
cold PBS and resuspended in buffer containing 30 mM
HEPES–KOH pH 7.6, 150 mM KOAc, 5 mM MgOAc2,
4 mM DTT, RiboLock RNase Inhibitor (ThermoFisher
Scientific) and 1× cOmplete™ Protease Inhibitor Cocktail
(Roche). Cell debris was removed by centrifugation at ∼15
000 g for 15 min and the resulting cleared cell lysate was
layered on a 0.5 ml sucrose cushion prepared in 30 mM
HEPES–KOHpH 7.6, 150 mMKOAc, 5 mMMgOAc2 and
centrifuged in a Beckman mini-ultracentrifuge for 2 h 30
min at 200 000 g in a S140AT rotor at 4◦C. The pellet (P100
– ribosome fraction)was re-suspended inHEPES–KOHpH
7.6, 150 mM KOAc and 5 mM MgOAc2 and the super-
natant (S100) was stored on ice. Ribosome content was es-
timated based on absorbance at 260 nm.
For in vitro translation 6.45 pmol of control HeLa or
NSUN5 KO HeLa P100 were mixed with 5 l HeLa S100
in a total volume of 20 l and pre-incubated for 10 min at
35◦C and 450 rpm. During this period, the majority of ribo-
somes that were already associated with mRNAs will termi-
nate translation. After pre-incubation, 2.1 l of translation
mixture containing 1.2l 10× translation cocktail (150mM
HEPES–KOH pH 7.6, 750 mMKOAc, 19.5 mMMgOAc2,
4 mM GTP, 17.5 mM ATP, 500 M 19 amino acids except
methionine), 0.17 l 100 mg/ml bulk yeast tRNA, 0.08 l
3M creatine phosphate, 0.06l 20mg/ml creatine phospho-
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kinase and 0.625 l 35S-methionine) were added to the re-
action (31). In vitro translation was performed at 35◦C and
rotation at 450 rpm for 30min, stopped by the addition of 8
l of 4× Laemmli buffer and incubation at 95◦C for 5 min.
Proteins were separated by 10% SDS PAGE and visualized
by Coomassie staining and 35S-methionine incorporation
by autoradiography.
Statistics
Statistical analysis and plotting of results were done in R,
version 3.5.1 (2018-07-02) [R Core Team (2017) R: A Lan-
guage and Environment for Statistical Computing. Vienna,
Austria: RFoundation for Statistical Computing. Retrieved
from http://www.R-project.org]. Depending on the shape
of the sample distribution, appropriate parametric or non-
parametric tests were used as indicated in the figure legend.
The number of replicates usually refers to independent bio-
logical replicates unless indicated otherwise. For bootstrap-
ping 95% confidence intervals for OPP-Assay, 1000 pseu-
dosamples of equal size to the original dataset were gener-
ated by random resampling with replacement. The differ-
ence in medians of each pseudosample (in regards to the
respective control) was calculated and the 2.5th and 97.5th
percentile of the sorted differences in medians were deter-
mined as the upper and lower confidence bounds of the CI.
RESULTS
NSUN5 is the human homolog of Rcm1p
We previously found that depletion of Rcm1p/NSUN-
5/Nsun5 extends lifespan in the model organisms Saccha-
romyces cerevisiae, Caenorhabditis elegans and Drosophila
melanogaster (12). To further investigate the underlying
molecular functions and their conservation in mammals,
we aligned the protein sequence of Rcm1p from S. cere-
visiae to all seven human NSUN-family members (Figure
1A and Supplementary Figure S1) to identify a putative
mammalian homolog. Evolutionary conservationwas high-
est in the catalytic region, which contains the S-adenosyl
methionine (SAM)-binding pocket and cysteines at posi-
tions C308 and C359, which are considered to be required
for covalent binding and release of the RNA substrate in
other RNAmethyltransferases (12,32,33). Subsequent phy-
logenetic analysis suggested that Rcm1p is closest related to
human NSUN5 (Figure 1B), which we therefore decided to
investigate further.
Loss of NSUN5 impairs growth of cells and mice
To study functional consequences of NSUN5 depletion in
a human cell model, we applied CRISPR–Cas9 to homozy-
gously delete NSUN5 in HeLa cells. In order to prevent
transcription of functional mRNA, we decided to target the
second exon of theNSUN5 gene and subsequently screened
clones originating from single cells for loss of NSUN5. We
were indeed able to isolate a single clonewhich showed com-
plete absence of NSUN5 protein expression (Figure 2A).
Sanger sequencing of genomic DNA from this clone re-
vealed a translocation from chromosome 4q into intron
1/exon 2 of theNSUN5 locus (Supplementary Figure S2A).
This led to loss of NSUN5 mRNA, as confirmed by RT-
qPCR (Supplementary Figure S2B).
During cultivation and expansion of this clone, we no-
ticed that cells appeared smaller and proliferated slower
than the parental HeLa cell line. To quantify this phe-
nomenon, we measured >6000 single cells and indeed ob-
served a small but significant decrease of 3.5% in median
cell diameter in NSUN5 KO (median = 16.85 m) com-
pared to control HeLa cells (median = 17.75 m) (Figure
2B). To exclude the possibility that this reduction of cell size
was due to off-target effects of CRISPR–Cas9, we stably
introduced a BACmid containing the GFP-tagged mouse
Nsun5 gene together with its endogenous promotor (27)
into NSUN5 KO (NSUN5 KO GFP-mNsun5) and con-
trol HeLa (HeLa GFP-mNsun5) cells. Western blot anal-
ysis confirmed expression of GFP-mNsun5 at the correct
size (Supplementary Figure S3A), while fluorescence mi-
croscopy revealed localization predominantly in the nucle-
oli and in the nucleoplasm (Supplementary Figure S3B). In-
deed, expression of GFP-mNsun5 partially rescued the size
defect in NSUN5 KO GFP-mNsun5 (median = 17.45 m)
compared to HeLa GFP-mNsun5 cells (median = 17.45
m) (Figure 2B). The remaining small but significant differ-
ence in size might be due to steric effects caused by fusion
to GFP or unexpected differential regulation of the mouse
genomic locus contained in the BACmid used by the human
transcriptional machinery.
To quantify our observation that loss of NSUN5 also de-
creases proliferation, we seeded equal numbers of HeLa,
NSUN5 KO, HeLa GFP-mNsun5 and NSUN5 KO GFP-
mNsun5 cells and recorded cell numbers every day. Indeed,
HeLa cells reached ∼40% higher cell numbers after three
days (Figure 2C), which was also reflected by a steeper
growth curve (Figure 2D). Ectopic expression of GFP-
mNsun5 slightly suppressed proliferation of HeLa cells, but
not of NSUN5 KO cells (Figure 2C, D). To further confirm
these results in normal cells, we introduced four different
small hairpinRNAs (shRNAs) targetingNSUN5, aswell as
a non-hairpin forming control, into three different strains of
human dermal fibroblasts (HDFs). After puromycin selec-
tion, reduced expression of NSUN5 mRNA was confirmed
by RT-qPCR (Supplementary Figure S4A) and reduced cell
numbers were observed in all fibroblast strains transduced
with shRNA constructs compared to the non-hairpin form-
ing control (Supplementary Figure S4B). To exclude the
possibility that the reduction of cell numbers was due to
acute infection stress, we re-seeded one of the HDF strains
at the same cell density and again, a decrease in prolifera-
tion upon NSUN5 depletion was evident (Supplementary
Figure S4C).
To assess the consequences of Nsun5 loss in mammals
in vivo, we deleted exon 1 of the Nsun5 gene in C57BL/6J
mice by CRISPR/Cas9, which resulted in Nsun5 knock-
out in the whole mouse body (Supplementary Figure S4D).
We confirmed that Nsun5 was indeed not expressed in these
mice at mRNA and protein level by RT-qPCR and western
blot (Supplementary Figure S4E and F). When recording
the weight of Nsun5 knockout and wildtype animals within
the same litter at either 4 or 8 weeks of age, we observed a
significant decrease in body weight by ∼10% in both sexes
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Figure 1. NSUN5 is the closest human homolog of Rcm1p. (A) Themultiple protein sequence alignment of Rcm1p and the humanNSUNprotein family is
shown. The sequences were cropped as follows: NSUN1 (336-586), NSUN2 (116–429), NSUN3 (84–333), NSUN4 (124–382), NSUN5 (182–424), NSUN6
(184–465), NSUN7 (244–507) and Rcm1p (198–489). The full-length alignment is shown in Supplementary Figure S1. Colors indicate similarities. Two
highly conserved cysteins required for covalent RNA substrate binding and subsequent release are indicated by asterisks (*). (B) Based on this alignment,
the depicted phylogenetic tree was constructed. Numbers indicate phylogenetic distances. NSUN5 (cyan) is the closest human homolog of yeast Rcm1p
(magenta).
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Figure 2. NSUN5 depletion decreases cell size and proliferation without affecting NRAS expression. (A) Western blot confirms loss of NSUN5 protein
expression in NSUN5 KO compared to HeLa cells. (B) Cell size was decreased in NSUN5 KO compared to HeLa cells. Horizontal lines within the violin
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upon loss of Nsun5, which was slightly more pronounced
in females than in males (Figure 2E). A similar trend was
visible in two other Nsun5 knockout mouse models, one
by the International Mouse Phenotyping consortium (34)
at 8 weeks of age (data included in Figure 2E), as well as
in a recent publication by Zhang and coworkers, although
not reaching statistical significance (21). Interestingly, also
adult Nsun5 knockout mice at 14–18 weeks of age were sig-
nificantly lighter than wildtypemice (Figure 2F). EchoMRI
measurements revealed that the weight difference between
wildtype and Nsun5 knockout animals was evident in lean
but not in fat mass (Figure 2F). Food intake of Nsun5
knockout mice (mean = 3.53 g/day) was slightly reduced
compared to wildtype animals (mean= 3.75 g/day), but did
not reach statistical significance (Figure 2G).
Herdy et al. found that NSUN5 interacts with the 5′UTR
of NRAS mRNA. As RAS represents a proto-oncogene
regulating cell growth, we speculated that the growth phe-
notypes we observed upon NSUN5 depletion might be
caused by changes in RAS expression. To test this hypoth-
esis, we measured RAS protein levels in HeLa and NSUN5
KO cells, but did not observe any differences (Figure 2H).
Taken together, these experiments clearly indicate that
NSUN5 is partially required for reaching a specific cell size
and for proliferation in mammals without influencing RAS
protein levels. Moreover, Nsun5 depletion resulted in re-
duced body weight of mice, prompting us to further inves-
tigate the underlying molecular mechanisms.
NSUN5 methylates C3782 of human and C3438 of mouse
28S ribosomal RNA
Since we previously did not observe similar size and growth
phenotypes in S. cerevisiae, C. elegans or D. melanogaster
upon NSUN5 depletion (12), we first aimed to confirm
that human NSUN5 methyltransferase activity is indeed
directed against a specific cytosine of 28S rRNA, as pre-
viously hypothesized in literature (10,11,35) and shown in
yeast, worms and human glioma cells (12,14,15). Therefore,
we compared the sequences of 28S rRNA of humans and
mice with the sequence stretch on 25S rRNA that is methy-
lated by Rcm1 in yeast (Figure 3A). Indeed, we observed
100% evolutionary conservation of the nucleotide sequence,
as well as conservation of many other known RNA modi-
fications, indicating functional importance of this region.
Due to the high similarity, we hypothesized that NSUN5
might methylate C3782 in humans. To test this hypothesis,
we performed bisulfite treatment of total RNA, followed
by reverse transcription, PCRamplification, TOPO-cloning
and Sanger-sequencing of 21 individual clones from HeLa
and NSUN5 KO cells, each. All 21 sequences of normal
HeLa cells showed no conversion of C3782 to uridine, indi-
cating that this residue of 28S rRNA was fully methylated.
In contrast, only 4 of 21 (19%) clones of NSUN5 KO cells
were not converted (Figure 3B). Thus, NSUN5 is clearly re-
sponsible form5Cmodification of C3782 of 28S rRNA.Our
findings are corroborated by another recent study, showing
that C3782 was the only methylation site altered upon ec-
topic expression of NSUN5 in a NSUN5 lacking glioma
cell line (15).
Due to the high evolutionary conservation of the se-
quence stretch of 28S rRNA (Figure 3A), we hypothesized
that Nsun5 methylates C3438 on 28S rRNA in mice. We
tested this hypothesis by using the same approach as for
HeLa cells with kidneys of Nsun5 knockout and littermate
control mice. Indeed, more than half of 17 clones of wild-
type mice showed methylation at C3438, in contrast to only
one single clone of Nsun5 knockout animals (Figure 3C),
confirming that Nsun5 is responsible for the modification
of C3438 of 28S rRNA in mice.
Two conserved cysteines of NSUN5 are required for its RNA
methyltransferase activity and normal proliferation
In order to confirm this result by a different and faster read-
out, we adapted the Combined Bisulfite Restriction Analy-
sis (COBRA) assay for detection of m5C2278 in yeast (13)
to human cells (Figure 4A). This approach confirmed the
results from Sanger-sequencing after bisulfite conversion,
also showing low potential residual methylation. To ex-
clude artefacts from using HeLa cells and off-target effects
by CRISPR–Cas9 deletion, we knocked down NSUN5
mRNA expression in HEK293 by shRNAs and observed,
despite low knockdown efficiency in this cell type (Supple-
mentary Figure S5A), a trend towards loss of m5C3782, al-
though not reaching statistical significance (Supplementary
Figure S5B).
Due to the high evolutionary conservation of NSUN5
and its rRNA target site between human and mouse, we
aimed to test whether mouse Nsun5 can rescue loss of
NSUN5 in human cells. Indeed, ectopic expression of en-
dogenous levels of GFP-mNsun5 encoded on the BACmid
←−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
indicate median, first and third quartile. n = 4 independent experiments with ≥6000 cells. *P ≤ 0.05, Kruskal–Wallis rank sum test with Dunn’s post-hoc
test. (C) HeLa, NSUN5 KO, HeLa GFP-mNsun5 and NSUN5 KO GFP-mNsun5 cells on days 1, 2 and 3 after seeding. Representative images of four
independent experiments are shown. Scale bar represents 50 m. (D) Analysis of cell proliferation by automated counting of viable cells. n= 4 independent
experiments with ≥6000 cells each. **P < 0.005, two-tailed Student’s t-test. ns = not significant. (E) The weight of Nsun5 knockout mice was decreased
compared to littermate controls. Each transparent data point represents the weight ratio of animals within a single litter of either 4 (circle) or 8 weeks
(square) of age. n ≥ 4 litters with 2–4 animals each. Data points represented by orange rectangles correspond to publicly available data of another Nsun5
knockout mouse model by the International Mouse Phenotyping Consortium (IMPC), with two knockout (–/–) versus 135 wildtype female (+/+) and 1
knockout (–/–) versus 150 wildtype (+/+) male mice at 8 weeks of age. Error bars indicate standard deviation. *P < 0.05, **P < 0.005, ***P < 0.0005,
one sample t-test against expected value of 1. (F) Total mass, lean mass and fat mass of adult mice at the age of 14–18 weeks assessed by Echo-MRI.
Total and lean mass were significantly decreased in Nsun5 knockout compared to wildtype mice. Fat mass revealed no significant differences upon Nsun5
knockout. Shapes of data points always refer to the same individual mouse per group. n = 5 per genotype and sex. Error bars indicate standard deviation.
*P < 0.05, Welch Two Sample t-test. (G) Food intake of male mice at the age between 15 and 19 weeks was calculated as mean of four consecutive days.
No difference between wildtype (+/+) and Nsun5 knockout (–/–) mice was observed. n = 5 (+/+), n = 6 (–/–). Welch Two Sample t-test. (H) Protein
expression levels of RAS and -Actin as loading control were analysed in HeLa and NSUN5 KO cells by western blot. Anti-Ras antibody reacts with
NRAS, VRAS and HRAS. Numbers represent quantitation of RAS expression relative to -Actin. The experiment was independently repeated two times
with similar outcome.
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Figure 3. NSUN5 methylates C3782 of 28S rRNA in human and C3438 in murine cells. (A) The sequence of 25S/28S ribosomal RNA surrounding
the putative methylation site of NSUN5 (orange color) is highly conserved between yeast, mice and humans. 2′-O-methyls are depicted in magenta and
pseudouridines () in green. (B) Bisulfite conversion and Sanger sequencing of RNA from HeLa and NSUN5 KO cells confirms C3782 methylation by
NSUN5. Figures indicate numbers of clones with (orange) or without (black) methylation. Pooled results from two independent experiments are shown.
Pooled n = 21 per condition. ***P < 0.0005, Fisher’s exact test for count data. (C) Bisulfite conversion and Sanger sequencing of RNA from kidneys of
wildtype (+/+) andNSUN5KO (–/–)mice confirmsC3438methylation byNSUN5.Numbers indicate clones with (orange) or without (black)methylation.
Pooled results from two independent experiments of littermate animals are shown. Pooled n = 17 per condition. **P < 0.005, Fisher’s exact test for count
data.
was able to fully restore methylation of m5C3782 in HeLa
cells (Figure 4B, C). Loss of human NSUN5 mRNA (Fig-
ure 4D) and gain of mouse Nsun5 mRNA (Figure 4E) were
confirmed by RT-qPCR.
To identify amino acid residues involved in the catalysis
of the methylation, we focused on two cysteine residues of
NSUN5 that we considered to be essential in the binding
and release of the substrate due to their conserved position-
ing and amino acid surroundings (Supplementary Figure
S1) (12,32,33).We then performed site directedmutagenesis
to exchange these cysteines to serines (C308S and C359S).
In fact, ectopic overexpression of human NSUN5 rescued
C3782 methylation defects as visualized by COBRA assay,
while C308S andC359Smutant versions of NSUN5 did not
(Figure 4F, G). Restored NSUN5 mRNA expression was
confirmed by RT-qPCR (Figure 4H). Moreover, ectopic ex-
pression of human wildtype NSUN5 in HeLa and mouse
embryonic fibroblast (MEF) cells lacking NSUN5 led to in-
creased proliferation compared to cells ectopically express-
ing the inactive C308S mutant (Figure 4I, J). We were not
able to test the C359S mutation, as several attempts to gen-
erate stable cell lines failed. We hypothesize that this might
be due to an inability to release covalently bound NSUN5
from the RNA, resulting in impaired rRNA biogenesis and
consequently cellular toxicity.
We therefore conclude that NSUN5 is responsible and re-
quired for introduction of m5C3782 within an evolutionar-
ily highly conserved region of 28S rRNA via two conserved
cysteine residues, while loss of this catalytic activity is di-
rectly linked to decreased proliferation.
RNA polymerase I activity and the N-terminal domain are
required for nucleolar localization of NSUN5
All four eukaryotic rRNAs are transcribed in the nucleolus
by RNA polymerases I and III, representing the first steps
of ribosome biogenesis. Consequently, the pre-ribosomal
particles are exported to the cytoplasm, where mature ribo-
somes are assembled (36–38). To test in which cellular com-
partmentm5C3782 is introduced byNSUN5, we performed
immunofluorescence staining of HeLa cells and analysed
endogenous NSUN5 localization by gated STED super res-
olution microscopy. Nucleoli were stained with an antibody
targeting fibrillarin (Figure 5A, Supplementary Figure S6).
As expected and also observed for GFP-mNsun5 (Sup-
plementary Figure S3B), NSUN5 was present in the cen-
tre of nucleoli, which suggests that m5C3782 is introduced
at an early stage of ribosome biogenesis. Next, we specifi-
cally blocked RNA polymerase II and III with -amanitin,
which left the nucleolar localization of NSUN5 and fibril-
larin undisturbed (Figure 5A). RNA polymerase II synthe-
sizes mRNAs and microRNAs, while RNA polymerase III
transcribes tRNAs and 5S rRNA (36,38). However, when
cells were exposed to 50 ng/ml actinomycin D to specif-
ically block RNA polymerase I (39–41) which transcribes
the pre-rRNA template that is further processed into 28S,
18S and 5.8S rRNA, both NSUN5 and fibrillarin segre-
gated to the nucleolar caps (Figure 5A), as previously de-
scribed for other nucleolar proteins as well (42).
Next, we aimed to test which part of NSUN5 is required
for nucleolar localization. NSUN5 is composed of three do-
mains: The N-terminal domain of unknown function and
predicted globular tertiary structure, the evolutionarily con-
served RNA methyltransferase domain including the SAM
binding pocket and two cysteines required for catalysis, as
well as the C-terminal domain of unknown function (Fig-
ure 5B, Supplementary Figure S1). First, we ectopically ex-
pressed full-length NSUN5 (NSUN5-GFP), as well as the
C308S and C359S mutants, with a C-terminal GFP-tag in
normal HeLa cells. Neither C308S nor C359S did affect nu-
cleolar localization (Figure 5C), indicating that the catalytic
activity is not required for targeting NSUN5 to its sub-
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Figure 4. Two conserved cysteines of NSUN5 are required for RNA methyltransferase activity and normal proliferation. (A) Principle of the COBRA
assay to measure m5C3782. Digestion with MseI generates two products (56 bp and 45 bp) in the presence of m5C3782 and three products (56, 29 and 16
bp) in the absence of m5C3782. A band at 101 bp represents the undigested PCR product. (B) COBRA assay of HeLa, NSUN5KO, HeLa GFP-mNSUN5
and NSUN5 KOGFP-mNSUN5 demonstrates that mouse Nsun5 fully restores methylation of C3782 upon loss of human NSUN5. A representative 20%
TBE gel of MseI-digested PCR products is shown. Numbers indicate size of fragments in basepairs. Arrow indicates methylation-specific band, whereas
asterisk (*) indicates band upon non-methylation. (C) Quantitation of COBRA assay in (B), n= 3 independent experiments. Error bars represent standard
deviation. ***P< 0.0005, one-way-ANOVA followed by a post-hoc Dunnet’s test. (D, E) mRNA expression levels of humanNSUN5 (D) and mouse Nsun5
(E) were analyzed by RT-qPCR. n = 3 independent experiments. Error bars represent standard deviations. ***P < 0.0005, one-way-ANOVA followed by
a post-hoc Dunnet’s test. (F) Representative COBRA assay of NSUN5 KO cells stably expressing the empty pCI-neo vector (EV) or pCI-neo containing
either NSUN5, NSUN5 (C308S) or NSUN5 (C359S) demonstrates the requirement of C308S and C359S for catalysis. (G) Quantitation of COBRA assay
in (F), n = 3 independent experiments. Error bars represent standard deviations. **P < 0.005, one-way-ANOVA followed by a post-hoc Dunnet’s test. (H)
Ectopic expression of NSUN5 in pCI-neo restores NSUN5 mRNA levels as analysed by RT-qPCR. n = 3 independent experiments. Error bars indicate
standard deviations. *P< 0.05, one-way-ANOVA followed by a post-hoc Dunnet’s test. (I, J) Analysis of cell proliferation by automated counting of viable
cells comparing NSUN5 KO HeLa (I) or MEF –/– (J) ectopically expressing either human NSUN5 or the C308S mutant on four consecutive days after
seeding. Error bars indicate standard deviations. n = 4 independent experiments. Western blots confirm ectopic expression of NSUN5 in both cell types.
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Figure 5. RNA polymerase I activity and presence of the N-terminal domain are required for nucleolar localization of NSUN5. (A) HeLa cells were
exposed to 50 g/ml -amanitin to block RNA Polymerase II and III or 50 ng/ml actinomycin D to block RNA Polymerase I, II and III. NSUN5 (green)
and fibrillarin (red) were visualized by indirect immunofluorescence staining. Confocal gSTED microscopy reveals nucleolar localization of NSUN5 and
segregation to nucleolar caps upon inhibition of RNA polymerase I. Images were processed by deconvolution and brightness and contrasts were adjusted.
Scale bar represents 3 m. The experiment was repeated twice with similar outcome (see also Supplementary Figure S6). (B) Protein domain structure of
NSUN5. The N-terminal globular domain (magenta), the RNAmethyltransferase domain (blue), the C-terminal domain (grey), the two cysteins required
for catalysis (C308 and C359, orange) and the SAM (S-adenosyl methionine) binding site (cyan) are depicted. Numbers indicate amino acids counted from
the N-terminus. (C) HeLa cells were transfected with NSUN5 (C308S, full-length), NSUN5 (C359S, full-length), NSUN5 (1–466, full-length), NSUN5 (1–
121), NSUN5 (1–277), NSUN5 (1–428), NSUN5 (121–466) and NSUN5 (277–466) as C-terminal GFP-fusions. Confocal microscopy revealed nucleolar
localization of all NSUN5 constructs (green) except NSUN5 (121–466) and NSUN5 (277–466). Nuclei were counterstained with Hoechst33342 (blue).
Microscopic images andNSUN5domain structure ofmutants are shown side by side. Images were processed by deconvolution and brightness and contrasts
were adjusted. Scale bar represents 5 m. The experiment was repeated twice with similar outcome.
strate. Thus, we generated truncation mutants of NSUN5-
GFP and observed that complete absence of the N-terminal
globular domain fully excluded NSUN5-GFP from nucle-
oli, while absence of the C-terminal domain only led to a
slight redistribution from nucleoli towards the nucleoplasm
(Figure 5C).
Taken together, these findings suggest that RNA poly-
merase I activity, as well as presence of the globular N-
terminal domain, and to a much lesser extend also of the
C-terminal domain, are required for nucleolar localization
of NSUN5. Consequently, we suggest that the addition of
m5C3782 occurs co-transcriptionally and is guided by the
globular N-terminal domain of NSUN5, representing the
functional targeting moiety.
Loss of NSUN5 reduces global protein translation but does
not affect ribosome biogenesis and fidelity
To further elucidate molecular mechanisms that might ex-
plain the observed growth and proliferation phenotype,
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we aimed to investigate the potential role of m5C3782 in
global protein translation in HeLa cells. Quantification of
O-propargyl-puromycin (OPP) incorporation by flow cy-
tometry (30) revealedmedian bulk translation to be reduced
by about 25% in NSUN5 KO (median = 0.379) compared
to control HeLa cells (median = 0.513) (Figure 6A). This
reduction in protein synthesis is directly connected with the
methylation activity of NSUN5, since ectopic expression of
wildtype NSUN5 in NSUN5 KO cells was able to rescue
OPP incorporation (median = 0.510), while expression of
the catalytically inactive mutant C308S was not (median
= 0.391) (Figure 6A). Similarly, comparison of polysome
profiles, which provide a snapshot of translational activ-
ity, showed an increase of 80S monosomes compared to
polysomes upon loss of NSUN5 (Figure 6B, C).
To confirm that alterations to the ribosome itself, and not
the number of ribosomes or other extrinsic factors, which
might also be influenced by loss of NSUN5, are responsi-
ble for decreased bulk protein synthesis, we decided to anal-
yse translation in vitro. For this aim, we depleted ribosomes
from a HeLa cell lysate by ultracentrifugation and spiked
this extract with equal amounts of purified ribosomes from
either control HeLa cells or NSUN5 KO cells, as well as
with 35S-Methionine to quantify protein synthesis. Thereby,
we observed a significant reduction in 35S-Methionine in-
corporation upon loss of NSUN5, whereas the size distri-
bution of newly synthesized proteins appeared to be simi-
lar (Figure 6D). Omission of the supernatant, which con-
tains several components necessary for translation includ-
ing mRNA, tRNAs, initiation, elongation and termination
factors, did not result in protein synthesis and thereby con-
firmed specificity of the assay. Quantification of in vitro syn-
thesized, radiolabelled protein over the full length of the au-
toradiogram revealed a reduction by 65% in NSUN5 KO
(mean = 0.35) compared to control HeLa cells (mean =
1) (Figure 6E). We confirmed equal loading of extracts by
Coomassie staining and equal amounts of ribosomes by
ethidium bromide staining for 5S and 5.8S rRNA (Figure
6F).
Importantly, the observed protein synthesis defect in
HeLa cells is not associated with decreased amounts of ma-
ture ribosomes per cell, as quantified by comparing 28S and
18S bands upon loading of total RNA from equal num-
bers of HeLa and NSUN5KO cells (Supplementary Figure
S7A). Furthermore, loss of NSUN5 in HeLa cells did not
induce any obvious alterations in ribosome biogenesis, as
evidenced by northern blot analysis with two specific pre-
rRNA probes (Supplementary Figure S7B–E).
Cancer cells, such as HeLa or glioblastoma, and cells of
embryonic origin, such as MEFs, require high global pro-
tein translation rates to maintain their fast proliferation
behavior. For this reason, we decided to measure protein
translation also in MEFs, as well as in various normal tis-
sues of wildtype and Nsun5 knockout mice in vivo by injec-
tion of OPP. OPP labelling of Nsun5 deficient MEFs (me-
dian = 0.335) indeed revealed a substantial reduction in
overall protein synthesis compared to wildtype control (me-
dian= 0.464), which could be rescued by ectopic expression
of human NSUN5 (median = 0.509), but not by the C308S
mutant (median = 0.384) (Figure 6G). Interestingly, quan-
tification of OPP incorporation into liver, kidney, lung and
bone marrow also showed a trend towards decreased pro-
tein synthesis in Nsun5 knockout animals compared to lit-
termate controls (Figure 6H), but to a lesser extent then in
MEFs.
Since we previously observed that loss of Rcm1, the
NSUN5 orthologue in yeast, increased stop-codon read-
through (12), and depletion of nsun-5 in a polyglutamine-
frameshifting C. elegans model caused elevated -1 trans-
lational frameshifting upon osmotic stress (43), we aimed
to test if loss of human NSUN5 also influences stop-
codon read-through or perturbs translational fidelity in
other ways. However, the recognition of any of the three
stop-codons was not affected in NSUN5 KO compared
to control HeLa cells upon transient transfection of dual
luciferase-based reporter constructs (Supplementary Fig-
ure S7F). Moreover, neither translational frameshifting in-
duced by viral sequences (44) (Supplementary Figure S7G),
nor amino acid misincorporation (45,46) were altered upon
NSUN5 loss (Supplementary Figure S7H). Additionally,
recognition of internal ribosome entry sites (IRES) (Sup-
plementary Figure S7I), which was previously reported to
be affected by pseudouridines in rRNA (47), was not differ-
ent in NSUN5 KO versus control HeLa cells.
Taken together, our findings indicate that presence of
NSUN5-mediated 28S rRNA methylation is required for
maintaining productive global protein synthesis, but not
translational fidelity, IRES recognition or ribosome biogen-
esis in mammals.
Partial loss of NSUN5 in Williams-Beuren-Syndrome is suf-
ficient to reduce m5C3782
NSUN5 is deleted in around 95%ofWBSpatients (48), who
show clinical phenotypes including growth retardation, a
dysmorphic face, behavioral and cognitive alterations, hy-
percalcaemia, as well as aortic and pulmonary stenosis (49).
While haploinsufficiency of the elastin gene was unambigu-
ously associated with the cardiovascular disease in WBS,
the question which other genes are dosage-sensitive and
contribute the clinical phenotype still remains unanswered
(49). Recently Zhang et al. observed cognitive impairments
in homozygous Nsun5 knockout mice, which were associ-
ated with a decrease in proliferation of oligodendrocyte pre-
cursor cells (21).
This prompted us to further investigate the functional
role of NSUN5 in WBS. To assess whether haploinsuffi-
ciency of the NSUN5 gene affects mRNA expression, we
compared NSUN5 mRNA levels in HDF of two WBS pa-
tients to two healthy donors. Indeed, we observed reduced
levels of NSUN5 mRNA in both cell strains derived from
WBS patients (Figure 7A). Similarly, reduced expression
of NSUN5 protein was detected by western blot (Figure
7B), while nucleolar localization of endogenous NSUN5
was not altered (Figure 7C). To test whether the partial
loss of NSUN5 is also sufficient to reduce methylation of
C3782, we performed COBRA assay and indeed observed
decreased C3782 methylation in HDF from two WBS pa-
tients compared to two healthy donors (Figure 7D, E).
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Figure 6. Loss of NSUN5 reduces global protein translation. (A) Total protein synthesis, analysed by OPP incorporation and flow cytometry, was reduced
in NSUN5 KO compared to control HeLa cells and could be rescued by ectopic expression of NSUN5 but not by the C308S mutant. Specificity was
verified by cycloheximide (CHX) exposure or omission of OPP (data not shown). Horizontal lines within the violin represent median, first and third
quartile. Pooled data from 4 independent replicates are shown. 5000 cells of each condition were randomly selected for analysis and normalized to the
sum of fluorescence intensities of all selected cells within the replicate. Bootstrapped 95% confidence intervals (CI) on difference in medians to HeLa in
%: NSUN5 KO = −27.3 to −25.3; NSUN5 KO ectopically expressing NSUN5 = −1.8 to 0.4; NSUN5 KO ectopically expressing C308S = −25.0 to
−22.8; CHX = −87.3 to −85.5. (B) Loss of NSUN5 increases the 80S monosome peak compared to polysomes in HeLa cells. Polysome profiling was
performed three times independently, representative profiles are shown. (C) Quantification of polysome profiles by calculating the area under the 60S, 80S
and polysome peak, respectively. Data were normalized to 60S. Error bars indicate standard deviation. *P< 0.05, one sample t-test against expected value
of 1. (D) Ribosomes of control HeLa and NSUN5 KO cells were purified and spiked into ribosome-free supernatant of HeLa cells. Autoradiogram shows
decreased amounts of nascent in vitro translated proteins upon NSUN5 loss. Purified ribosomes without supernatant verified specificity and Coomassie
staining confirmed equal loading. (E) Quantitation of autoradiograms demonstrate less in vitro translation in NSUN5 KO compared to control HeLa
cells. Error bars indicate standard deviation. *P < 0.05, one sample t-test against expected value of 1. (F) Ethidium bromide staining of a denaturing
polyacrylamide gel confirms equal loading of purified ribosomes. (G) Total protein synthesis, analysed by OPP incorporation and flow cytometry, of MEF
–/– was reduced compared to MEF +/+ cells and could be rescued by ectopic expression of NSUN5 but not by the C308S mutant. Specificity was verified
by cycloheximide (CHX) exposure or omission of OPP (data not shown). Horizontal lines within the violin represent median, first and third quartile.
Pooled data from three independent replicates are shown. 5000 cells of each condition were randomly selected for analysis and normalized to the sum of
fluorescence intensities of all selected cells within the replicate. Bootstrapped 95% confidence intervals (CI) on difference in medians to MEF +/+ in %:
MEF –/– = −29.2 to −26.1; MEF -/- ectopically expressing NSUN5 = −8.3 to 11.6; MEF –/– ectopically expressing C308S = −18.7 to −15.5; CHX =
−87.1 to−84.7. (H) Total protein synthesis in vivowas analysed by injection of OPP and flow cytometry of single cell suspensions of kidney, liver, lung and
bone marrow. Specificity was verified by injection of PBS (ctrl). N = 5 animals per condition in two independent experiments (indicated by either filled or
empty symbols). Welch Two Sample t-test: Kidney: P = 0.7313; mean +/+ = 7.730, mean –/– = 7.274; Liver: P = 0.7882, mean +/+ = 5.1526, mean –/–
= 4.9744; Lung: P = 0.1684, mean +/+ = 2.102, mean –/– = 1.600; bone marrow: P = 0.7305, +/+ = 6.162, mean –/– = 5.140.
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Figure 7. Partial loss of NSUN5 in Williams-Beuren-Syndrome is sufficient to reduce m5C3782. (A) Relative expression levels of NSUN5 mRNA of two
healthy donors as well as two WBS patients were determined by RT-qPCR. (B) Protein expression levels of NSUN5 were measured in fibroblasts of a
healthy donor and two WBS patients. (C) DIC and IF images of fibroblasts of a healthy donor and the two WBS patients. NSUN5 is stained in green
and nuclei are counterstained with DAPI. Scale bar represents 10 m. (D) COBRA assay of fibroblasts of two healthy donors and two WBS patients
indicates that methylation of C3782 is decreased in WBS. A representative 20% TBE gel of MseI-digested PCR products is shown. Numbers indicate
size of fragments in basepairs. Arrow indicates methylation-specific band, whereas asterisk (*) indicates band upon non-methylation. (E) Quantitation of
COBRA assay in (D).
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Thus, we conclude that NSUN5 expression is lower
in HDF from WBS patients compared to cells from
healthy donors on both mRNA and protein level. Further-
more, reduced NSUN5 expression also results in decreased
C3782 methylation. However, further studies in heterozy-
gous Nsun5 knockout mice are required to assess whether
the reduced gene dosage by Nsun5 haploinsufficiency is
enough to induce similar cognitive deficits that were ob-
served in Nsun5 full knockout mice (19–21).
DISCUSSION
We here report that loss of NSUN5 induces growth phe-
notypes in mice and different mammalian cells, which is
likely connected to the requirement of NSUN5 for riboso-
mal RNA modification and normal global protein transla-
tion, especially in highly proliferative cells. However, we can
also not fully rule out that NSUN5 directly disturbs one of
themain growth pathways or RAS activity without interfer-
ingwithRASprotein levels. But howmight loss ofm5C3782
affect the ribosome?
Upon assembly of the SSU and LSU to active 80S ribo-
somes, the eukaryote-specific bridge eB14 is formed, which
directly contacts rRNAbasemodifications of both subunits
including m5C3782. This residue, which we have shown to
be methylated by NSUN5, is located within helix 70, do-
main IV on 28S rRNA and interacts with RPL41, a small
but highly positively charged protein and main constituent
of eB14, which expands from the 60S and protrudes into a
binding pocket of the 40S DCS (50). Although not much is
known about the presence and precise function of the eB14
bridge in humans (10,11,50), NSUN5-guided methylation
of C3782 might play an important part in its formation and
thereby modulate global protein translation.
Accumulating evidence for the presence of ‘specialized ri-
bosomes’, which are generated in response to various stim-
uli and promote the selection of specific mRNAs for trans-
lation (6,7), fuels the hypothesis that presence or absence of
certain rRNA modifications might contribute to ribosome
heterogeneity on a structural and functional level. Our dis-
covery that NSUN5, being required for the addition of a
specific methylation to 28S rRNA in humans and mice, co-
localizes with fibrillarin in the centre of nucleoli suggests
that addition of m5C3782 might constitute an early event
during ribosome biogenesis happening co-transcriptionally,
as was already reported for 2′O-methylations introduced
by fibrillarin (51,52). As m5C3782 is located in the core of
mature ribosomes, this site appears unlikely to be accessi-
ble for hypothetical cytoplasmic RNA methylases or de-
methylases. Since the response time of transmitting a sig-
nal via NSUN5-guidedmethylation of rRNA in the nucleo-
lus to mature (specialized) ribosomes leading ultimately to
altered mRNA translation patterns would be rather slow
compared to other cellular regulatory loops, we consider
it hardly probable that NSUN5 plays an active role in
the translational regulation of gene expression. Nonethe-
less, the identification of potential upstream regulators of
NSUN5 expression and activity is important and will be
further studied, as tight regulation of NSUN5 expression
levels seems to be crucial for cellular fitness.
Recent studies revealed almost complete methylation at
C3782 in HeLa (53) and at C3438 in mouse embryonic stem
cells (54). However, as we found only partial methylation in
mouse kidney, it will be interesting to determine in future
studies if these discrepancies are caused by artefacts due to
the much lower sequencing depth of our approach. In ad-
dition, methylation levels might be influenced by the tissue
context or the proliferative capacity of cells.
Equally important will be the identification of potential
additional RNA substrates of NSUN5 by global bisulfite
sequencing, Aza-IP or miCLIP (33,53–56), which will also
clarify whether the recently described physical association
of NSUN5with NRASmRNA in cytoplasmic extracts (57)
results in NRAS mRNA methylation, or if NSUN5 ful-
fils other non-canonical functions there. Surprisingly and
contradictory to the study by Herdy and coworkers (57),
we did not observe cytoplasmic localization of NSUN5,
neither with two different antibodies detecting endogenous
NSUN5, nor by ectopic expression of different GFP-tagged
NSUN5 constructs. This suggests that either only small
amounts of NSUN5 shuttle to the cytoplasm, or that ex-
tracts used for pulldowns might have contained small resid-
ual amounts of nuclear proteins and mRNAs. Anyhow,
since RAS is an important stimulator of mTORC1 activ-
ity (58), it thereby promotes cytoplasmic translation and
growth further downstream. Thus, subtle differences in
RAS signalling and molecular function between different
organisms might partially explain why loss of NSUN5 im-
pairs growth in mice and human cells, but not in yeast,
worm and fly (12).
We previously reported that NSUN5 orthologs modu-
late the chronological lifespan of yeast, as well as organ-
ismal lifespan of C. elegans and D. melanogaster. Impor-
tantly, this lifespan extension was conditional to reduced
nutrient availability and was not accompanied by any obvi-
ous phenotypical alterations, such as body size, locomotion
or feeding behaviour (12). C. elegans and D. melanogaster
are predominantly post-mitotic organisms, thus impaired
proliferation of cells is unlikely to affect organismal fitness
and depletion of Rcm1 in yeast only extended chronolog-
ical, but not replicative lifespan (12). Further experiments
with our Nsun5 knockout mouse model will clarify, if loss
of Nsun5 is able to modulate healthy lifespan of a complex
model organism with characteristics of both chronological
and replicative ageing.
In contrast to the small model organisms, we here discov-
ered that loss of NSUN5 or catalytic mutation impairs ribo-
some function and reduces size and proliferation in mam-
malian cells, as well as the body weight of mice. These dis-
agreements might be due to important differences between
the models. NSUN5 depletion reduced bulk protein trans-
lation inmammalian cells, while a similar response was only
evoked in yeast and C. elegans by exposure to stress such as
hydrogen peroxide (12) or high salt concentrations (13,43).
This might indicate that loss of m5C3782 renders ribosomes
instable, which yeast and nematodes in contrast to mam-
malian cells are able to compensate under unstressed con-
ditions.
Also, cells with high proliferation rates, such as cancer
cells (HeLa, certain glioma cell lines under oxidative stress
(15)) and immortalized cell lines (MEF), seem to be sensi-
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tive to loss of NSUN5, while in mice several normal tissues
with lowproliferation rates, including kidney, liver, lung and
bone marrow were only mildly affected. Thus, we hypothe-
size that blunted expression ofNsun5, either by knockout or
endogenous hypermethylation of its promoter, will mostly
influence highly proliferative tissues of the adult mouse,
which might explain the relatively mild general phenotype.
Indeed, differential regulation of NSUN5 expression in var-
ious tissues was recently demonstrated to happen at epige-
netic level, since methylation of the NSUN5 promoter was
high in some glioma cell lines and primary tumors, but low
in cervical and other malignancies (15). Thus, it will be in-
teresting to determine epigenetic silencing of the NSUN5
locus also in various normal tissue contexts.
Importantly, the ancestral gene NSUN5, which we here
investigated, has two additional copies (NSUN5B and
NSUN5C) in the same chromosomal region related to
WBS. All three gene products are described to be ubiqui-
tously expressed and showing tissue-specific patterns (18).
Weak expression of NSUN5 and high background stain-
ing of available antibodies did not allow us to assess which
of the predicted genes are indeed expressed. However, only
full-length NSUN5 is likely to participate in methylation
of rRNA, because NSUN5B and NSUN5C roughly cor-
respond to GFP-tagged truncation mutants, which did not
localize to nucleoli. However, we cannot rule out specific
functions of these genes in the cytoplasm or in another tis-
sue context.
One of the main features of WBS is a mild to moderate
cognitive impairment, including reduced cerebral volume
by 13% (59,60). Recently, Zhang and coworkers described a
novel Nsun5 knockout mouse model in the same C57BL/6J
genetic background as our Nsun5 knockout mice. They
demonstrated that loss of Nsun5 led to deficits in spatial
learning and memory capacity, which might be connected
to WBS pathology (20,21). Our data presented here further
support this hypothesis in several ways: (i) Reduced prolif-
eration of oligodendrocyte precursor cells in Nsun5 knock-
out mice (21) is most likely a general consequence of Nsun5
depletion, as we observed similar proliferation deficits in
several other primary and immortalized cell types, (ii) al-
terations of ribosomes and protein translation, which we
also observed upon NSUN5 loss, are frequently linked to
other neuronal pathologies (61,62), and (iii) we were able
to demonstrate that primary fibroblasts fromWBS patients
indeed showed decreased NSUN5 mRNA and protein lev-
els resulting in a reduction of m5C3782, which clearly indi-
cates that gene-dosage by haploinsufficiency of the NSUN5
gene inWBS is relevant.However, further studies with other
cell types, more donors and advanced disease models, such
as mice heterozygous for the Nsun5 gene, are required to
draw definite conclusions and identify further symptoms
that might be linked to NSUN5 haploinsufficiency. Better
understanding of these molecular mechanisms will then po-
tentially allow the development of novel therapeutics target-
ing the cognitive phenotype of WBS.
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